On Dec. 21, 2023, CSL and and Arcturus Therapeutics announced the results of a Phase 3 study showing…
On Dec. 18, 2023, COVID-19 vaccine maker BioNTech (22UAy.DE) announced that it aims to start production at its…
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
On Nov. 28, 2023, CSL and Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor and Welfare (MHLW)…
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) had granted full approval for Novavax’s…
On Oct. 3, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
On Jul. 25, 2023, U.S. National Science Foundation-supported research, led by Joshua Rosenthal of the Marine Biological Laboratory…
On Jul. 18, 2023, scientists reported that they had extracted, sequenced, and analyzed historical RNA from muscle and…
On Apr. 27, 2023, a NIAID-led Phase 2 trial compared two Pfizer bivalent mRNA COVID-19 boosters found that…
On Apr. 25, 2023, the U.S. FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS)…
On Mar. 30, 2023, Moderna and the Government of the Republic of Kenya announced they had finalized an…
On Mar. 15, 2023, scientists at Texas A&M announced that a research study: ﾓRNA interference is essential to…
On Feb. 17, 2023, Moderna announced that Health Canada had authorized the use of its Omicron-targeting bivalent COVID-19…
On Feb. 9, 2023, the National Institutes of Health (NIH) announced that a new large-scale genetic analysis found…
On Jan. 17, 2023, Moderna announced positive topline data from its ConquerRSV Phase 3 pivotal efficacy trial of…
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
On Dec. 23, 2022, BioNTech and Fosun Pharmaceutical announced that they had received the certificates of registration as…
On Dec. 21, 2022, Moderna announced the the finalization of a strategic partnership with the United Kingdom (UK)…
On Dec. 16, 2022, Moderna announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use…
On Dec. 9, 2022, Pfizer and BioNTech announced the companies had received Fast Track Designation from the U.S….
On Dec. 8, 2022, Moderna announced it had received emergency use authorization from the U.S. Food and Drug…
On Nov. 16, 2022, Pfizer and BioNTech announced that the companies had initiated a Phase 1 study to…
On Nov. 14, 2022, Moderna announced that both of Moderna’s bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger…